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Background: EmrE is a dual-topologymembrane protein, but it is not clear whether the active form is composed of parallel
or anti-parallel dimers.
Results: Antiparallel EmrE dimers are more stable than parallel dimers.
Conclusion: Antiparallel EmrE dimers most likely correspond to the functional form of the protein.
Significance: The results provide new information on the functional form of EmrE.
The bacterial multidrug transporter EmrE is a dual-topology
membrane protein and as such is able to insert into the mem-
brane in two opposite orientations. The functional form of
EmrE is a homodimer; however, the relative orientation of the
subunits in the dimer is under debate. Using EmrE variants with
fixed, opposite orientations in the membrane, we now show
that, although the proteins are able to form parallel dimers, an
antiparallel organization of the subunits in the dimer is pre-
ferred. Blue-nativePAGEanalyses of intact oligomers anddisul-
fide cross-linking demonstrate that in membranes, the proteins
form parallel dimers only if no oppositely orientated partner is
present. Co-expression of oppositely orientated proteins almost
exclusively yields antiparallel dimers. Finally, parallel dimers
can be disrupted and converted into antiparallel dimers by heat-
ing of detergent-solubilized protein. Importantly, in vivo func-
tion is correlated clearly to the presence of antiparallel dimers.
Our results suggest that an antiparallel arrangement of the sub-
units in the dimer ismore stable than a parallel organization and
likely corresponds to the functional form of the protein.
EmrE is a prototypical Escherichia coli inner membrane pro-
tein belonging to the small multidrug resistance family of sec-
ondary transporters (1). It imparts resistance to toxic com-
pounds such as ethidium bromide (EtBr) and acriflavin (2).
EmrE is 110 amino acids long and has four transmembrane
helices. The minimal functional unit is a homodimer (3). Bio-
chemical (4–7) and phylogenetic data (8) support a so-called
dual topology for EmrE, i.e. the monomers have a mixed mem-
brane orientation. Although it seems clear that the wild-type
monomer is a dual-topology protein, the relative orientation of
the subunits in the functional dimer is under debate.On the one
hand, the available two-dimensional and three-dimensional
crystal structures (9, 10) and recent FRET and NMR studies
(11) show EmrE as an antiparallel dimer formed by two oppo-
sitely orientatedmonomers. On the other hand, parallel dimers
have been detected by chemical cross-linking (12) and a model
proposing that both parallel and antiparallel dimers are active
has recently been put forward, together with the proposition
that the affinity for parallel association is higher than for antipa-
rallel association (7, 13).
In support of the antiparallel EmrE dimer being the more
active species, we have shown previously that engineered EmrE
variants with a predominant Cin or Cout orientation in the
membrane (EmrE(Cin), EmrE(Cout)) impart no or very weak
resistance to EtBr when expressed alone at low levels, whereas
equally low level co-expression of the two variants provides
robust resistance (4).When expressed at high levels in aemrE
strain, EmrE(Cin) imparts some resistance to EtBr; however,
considerably less than what is seen when wild-type EmrE is
expressed under the same conditions (7). It is not clear whether
this activity is the result of weakly active parallel EmrE(Cin)
dimers or if it is due to a small amount of EmrE(Cin) monomers
that are in fact oppositely orientated, thereby allowing some
formation of antiparallel dimers.
To better characterize the various dimer populations
obtained with the different EmrE variants, we have now ana-
lyzed dimer formation in vivo and in vitro, using spontaneous
disulfide bond formation and blue-native PAGE (BN-PAGE).3
We have also confirmed the predominant Cin and Cout topolo-
gies for EmrE(Cin) and EmrE(Cout) by cysteine-labeling of non-
tagged proteins in intact cells.
Our results show that both EmrE(Cin) and EmrE(Cout) are
able to form parallel homodimers when expressed alone, but
that the antiparallel EmrE(Cin)/EmrE(Cout) heterodimer is the
favored species when EmrE(Cin) and EmrE(Cout) are co-ex-
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pressed in the same cell. This observation implies that in vivo,
antiparallel dimers are more stable than parallel dimers. In
agreement with this observation, when EmrE(Cin)/EmrE(Cout)
heterodimers are solubilized in dodecylmaltoside (DDM) and
heated to 60 °C to reversibly disassociate the dimer, the sample
re-equilibrates into an approximate 1:2:1 mixture of EmrE(Cin)
homodimer, EmrE(Cin)/EmrE(Cout) heterodimer, and EmrE-
(Cout) homodimer upon cooling. A similar 1:2:1 equilibrium
is obtained when separately prepared samples of DDM-solubi-
lized EmrE(Cin) and EmrE(Cout) homodimers are combined,
heated to 60 °C, and cooled. The 1:2:1 distribution suggests that
the three reassembled dimer forms are of nearly equal stabilities
and correspond to antiparallel homo- and heterodimers. i.e.
that, after dissociation of both parallel and antiparallel dimers
in detergent, monomers reassemble preferentially into antipa-
rallel dimers.
Taken together, our observations suggest that an antiparallel
organization of the subunits in the EmrE dimer is more stable
than either Cin- or Cout-orientated parallel dimers. In previous
experiments, we demonstrated that maximum EtBr resistance
is seen with cells either expressing the dual-topology
EmrE(WT) or co-expressing EmrE(Cin) and EmrE(Cout) (4).
We therefore conclude that the antiparallel dimer is not only
the more active but also the more stable species.
EXPERIMENTAL PROCEDURES
Enzymes and Chemicals—All enzymes were from Fermentas
(St. Leon-Rot, Germany), except for Pfu Turbo DNA polymer-
ase from Stratagene (La Jolla, CA), complete supplement mix-
ture of amino acids minus methionine (CSM Amino Acids,
Met) from MP Biomedicals (Illkirch Cedex, France) and T4
DNA Ligase from Invitrogen. Oligonucleotides were from
EurofinsMWGOperon (Ebersberg, Germany) and CyberGene
(Stockholm, Sweden). L-[35S]methionine was from PerkinEl-
mer Life Science. DDM and 2-(trimethylammonium)ethyl)
methane thiosulfonate bromide (MTSET) were from
Affymetrix-Anatrace (HighWycombe, UK). All other reagents
were from Sigma-Aldrich.
Cloning and Mutagenesis—Cysteine-less EmrE variants
(C39S, C41S, C95S), subsequent cysteine replacements, and
Myc-His-tagged variants were generated by PCR mutagenesis
of genes encoding EmrE, EmrE-Cin(R29G, R82S, S107K), and
EmrE-Cout (T28R, L85R, R106A) (4). All constructs were
cloned into the pETDuet-1 vector (Novagen), either solely or in
pairs. The vector contains two multiple cloning sites (MCS),
each preceded by a T7 promoter/lac operator and a ribosome
binding site. Three combinations of primer-introduced restric-
tion sites were used for cloning purposes: 5-NcoI/3-BamHI
and 5-NcoI/3-SacI (EmrE-MycHis) for MCS1 and 5-NdeI/
3-XhoI forMCS2. The 5-restriction site inMCS1 results in an
extra Gly residue following the initial Met; this does not affect
the activity of the protein. All constructs were confirmed by
DNA sequencing at Eurofins MWG Operon (Ebersberg,
Germany).
Selective Radiolabeling and Spontaneous Cross-linking—
Proteinswere labeled selectivelywith [35S]methionine using the
rifampicin-blocking technique (14). E. coli BL21(DE3) cells
expressing single-cysteine EmrE variantswere grown to anA600
of 0.5 at 37 °C. Cells were harvested by centrifugation at 1300
 g for 5 min in a tabletop Eppendorf centrifuge, resuspended,
and starved for 90 min in minimal medium (M9 salts, 100
g/ml thiamine, 0.1 mM CaCl2, 1 mM MgSO4, 0.4% glucose, 1
mg/ml CSM amino acids minus methionine, 100 g/ml ampi-
cillin). After inducing with 1 mM isopropyl 1-thio--D-galacto-
pyranoside for 10 min, 0.2 mg/ml rifampicin was added, and
incubation was continued for 15 min. Proteins were labeled
with 15 Ci [35S]Met for 3 min and put on ice for 2 min to stop
the reaction. The samples were analyzed by 15% SDS-PAGE,
and gels were imaged with Fujifilm FLA-3000. For reducing
conditions, 50 mM dithiothreitol phosphate (DTT) was added
prior to SDS-PAGE.
Topology Determination by Cysteine Labeling—For cysteine
labeling, the protocol was adapted from Ref. 7 with some mod-
ifications. Selectively radiolabeled cells were harvested at 1300
 g for 4min at 4 °C in a tabletop Eppendorf centrifuge, washed
with potassium phosphate buffer (100 mM potassium phos-
phate, pH 7.0, 50 mM NaCl), resuspended in potassium phos-
phate buffer, and 0.14mMMTSET, immediately harvested, and
washed twice with potassium phosphate buffer. Cells were
lysed in 30 mM Tris-Cl, pH 7.0, 50 g/ml lysozyme, small
amounts of DNase, and 5 mM MgCl for 30 min at 30 °C. The
membrane fraction was collected by ultracentrifugation (20
min at 250,000 g in aTLA-100.3 rotor) and incubated at 37 °C
for one hour in 2% SDS, 6 M urea, 15mMTris-Cl, pH 7.5, and 25
mM methoxypolyethylene glycol maleimide (Mal-PEG). Sam-
ples were buffered with 100mMTris-HCl, pH 6.8, and analyzed
by 15% SDS-PAGE and gels imaged with Fujifilm FLA-3000.
Analysis of Dimer Formation by BN-PAGE—EmrE variants
were labeled with [35S]Met as described above, and the prepa-
ration of the samples was carried out as described in Ref. 15.
Cells were lysed in water and 0.4 mg/ml lysozyme (45 min at
30 °C and slow shaking), and the membrane fraction was col-
lected by ultracentrifugation (40 min, 200,000  g, 4 °C using
TLA55 rotor). The pellet was resuspended in ACA buffer (750
mM amino-n-caproic acid, 50 mM Bis-Tris, 0.5 mM EDTA, pH
7.0), andDDMwas added to a final concentration of 0.5% (w/v).
After 1-h incubation on ice, non-solubilized material was
removed by ultracentrifugation (40 min, 200,000  g in TLA55
rotor at 4 °C) and G250 solution (5% (w/v) Coomassie Brilliant
Blue G in ACA buffer) was added to the supernatant. The sam-
ples were loaded on a 5–15%BN gradient gel (14 cm 20 cm
1.5 mm) and run at 75 V, 10 mA/gel for 1 h, and 385 V, 10
mA/gel for 17 h at 4 °C.Gelswere fixed, dried, and scannedwith
Fujifilm FLA-3000. Data were analyzed with Image Gauge (ver-
sion 4.23, Fujifilm) and QtiPlot (version 0.9.8.3, ProIndep Serv
S.r.l.). For some experiments, samples were incubated at 60 °C
after solubilization in DDM and removal of non-solubilized
material by ultracentrifugation. After cooling down,Coomassie
Brilliant BlueG-solutionwas added to the samples, and samples
were analyzed as described above.
Two-dimensional SDS-PAGE—The gel strip cut from the
first dimensionBN-PAGEwas equilibrated in buffer containing
2% (w/v) SDS, 250mMTris-Cl, pH 6.8, and 100mMDTT for 30
min. The strip was fixed onto a 15% and 14 cm  20 cm  1.5
mM SDS gel and run for 14 h at 250 V. Gels were fixed, dried,
and scanned with Fujifilm FLA-3000.
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Topology Mapping of EmrE(Cin) and EmrE(Cout) by Cysteine
Labeling—As noted in the introduction, EmrE(WT) has a dual
topology and functions as a homodimer. In earlier work (4, 5),
we showed that the orientation of EmrE in the cytoplasmic
membrane of E. coli is sensitive to the distribution of positively
charged residues in the parts of the protein that flank the four
transmembrane helices, and we exploited this sensitivity to
engineer EmrE variants that are inserted into the membrane
with a unique Cin or Cout orientation (Fig. 1A) (4).
In these experiments, the topology of the engineered variants
was determined using C-terminal fusions to the topology
reporters PhoA andGFP. Because themembrane orientation of
EmrE(WT) has been found to be sensitive to the addition of
certain C-terminal tags (4, 7), we decided to adapt a cysteine-
labeling procedure described by Nasie et al. (7) to obtain inde-
pendent topological data for EmrE(Cin) and EmrE(Cout) with-
out the use of tags. In this assay, cells expressing selectively
radiolabeled EmrE constructs containing a single cysteine res-
idue are treated with the small membrane-impermeable rea-
gent (MTSET), which reacts with cysteines that are exposed
to the periplasm without causing noticeable changes in the
molecular weight of the protein. Following cell lysis, unre-
acted thiols are identified by reaction with Mal-PEG, a rea-
gent that increases themolecular weight of the protein by5
kDa, a shift in molecular mass that is detected readily by
conventional SDS-PAGE. In this way, periplasmically
exposed cysteines can be differentiated from cysteines not
exposed to the periplasm.
Because no antibodies against EmrE are available, we visual-
ized EmrE on SDS-PAGE by [35S]Met labeling of EmrE con-
structs expressed from a T7 promoter in cells expressing T7
RNA polymerase, using rifampicin to block endogenous tran-
scription (14). A single cysteine residue was introduced close to
the C terminus (T108C) in otherwise cysteine-less versions of
EmrE(Cin) and EmrE(Cout) (Fig. 1A). PEGylation was efficient
for EmrE(Cin)T108C (Fig. 1B, lanes 1 and 2), indicating that
Cys108 faces the cytoplasm, whereas for EmrE(Cout)T108C,
MTSET blocked the PEGylation reaction (Fig. 1B, lanes 5 and
6), as expected if Cys108 faces the periplasm. This confirms the
FIGURE 1. Topology mapping of EmrE variants by cysteine accessibility. A, schematic representations of the oppositely orientated EmrE variants, EmrE(Cin)
and EmrE(Cout). The mutations in EmrE(Cin) are R29G, R82S, and S107K, and in EmrE(Cout) T28R, L85R, and R106A. Black dots represent positively charged
residues. The white starburst represents the position of the single cysteine Cys108 used for topology determination by MTSET/Mal-PEG treatment of whole cells.
B, cysteine labeling of EmrE(Cin)
T108C and EmrE(Cout)
T108C. Periplasmic cysteines were blocked by treatment of whole cells with membrane-impermeable
MTSET, cells were lysed, and remaining free cysteines were reacted with Mal-PEG that causes a size shift (black dots). The disulfide-bonded dimer of
EmrE(Cout)
T108C is indicated by a white dot. C, SDS-PAGE gels showing spontaneous in vivo cysteine cross-linking of EmrE(Cout)
T108C (lane 3, white dot) but not
of EmrET108C, EmrE(Cin)
T108C, or co-expressed EmrE(Cin)/EmrE(Cout)
T108C (lanes 1, 2, and 4). Lanes 5– 8 shows the same samples after reduction with DTT. Note
that EmrE(Cin) migrates faster than EmrE(Cout) and EmrE(WT) on SDS-PAGE gels.
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orientations of EmrE(Cin) and EmrE(Cout) as determined by
reporter fusions.
EmrE(Cout)T108C Forms Disulfide-bonded Dimers in Vivo—
Interestingly, for EmrE(Cout)T108C, a band of the size expected
for a disulfide-bonded dimer was observed in the absence but
not in the presence of the reductantDTT (Fig. 1B, lanes 5 and 7;
Fig. 1C, lanes 3 and 7). Incubation withMTSET/Mal-PEG after
cell lysis does not prevent dimer formation (Fig. 1B, lane 6),
indicating that EmrE(Cout) can form a parallel homodimer
already in the inner membrane of intact cells.
In contrast, no dimer was seen when EmrE(Cout)T108C was
co-expressedwithCys-less EmrE(Cin) (Fig. 1C, lane 4), suggest-
ing that formation of the antiparallel EmrE(Cout)/EmrE(Cin)
heterodimer may outcompete formation of the EmrE(Cout)
homodimer. The dual-topology EmrE(WT)T108C does not form
a disulfide-bonded dimer, as expected if the EmrE(WT)
homodimer is antiparallel (Fig. 1C, lane 1). No disulfide-
bonded dimer is seen for EmrE(Cin)T108C when it is expressed
on its own (Fig. 1B, lane 1; Fig. 1C, lane 2) because Cys108 faces
the cytoplasm in this case. We conclude that EmrE(Cout) can
form parallel homodimers in the inner membrane when
expressed on its own but not when co-expressed with EmrE-
(Cin), providing a first indication that the antiparallel EmrE-
(Cout)/EmrE(Cin) heterodimer may be more stable than the
parallel EmrE(Cin) homodimer.
Analysis of EmrE Homo- and Heterodimers by BN-PAGE—
Tovisualize all homo- andheterodimers formed by EmrE(WT),
EmrE(Cin), and EmrE(Cout), we used BN-PAGE to separate
protein complexes under non-denaturing conditions. All three
proteins migrate predominantly as dimers when extracted into
DDM and analyzed by BN-PAGE (Fig. 2A, lanes 1, 3, and 6).
Some higher oligomers, most likely tetramers, are also seen in
all samples. A notable amount of monomer is seen for EmrE-
(Cout) but not for EmrE(WT) or EmrE(Cin). Fortuitously, the
EmrE(Cout) dimer migrates noticeably faster than do the
EmrE(WT) and EmrE(Cin) dimers, making it possible to distin-
guish homo- and heterodimers when the different EmrE ver-
sions are co-expressed.
Co-expression of EmrE(Cin) and EmrE(Cout) from the same
plasmid yields a heterodimer with a mobility that is intermedi-
ate between that of the EmrE(Cin) and EmrE(Cout) homodimers
(Fig. 2A, see inset). Only small amounts of EmrE(Cin) or EmrE-
(Cout) homodimer are present in this case. Notably, the two
cloning sites in the vector yield somewhat different amounts of
protein (Fig. 2C) and the remaining homodimer that is seen
correlates with the monomer that is present in excess. Analysis
by two-dimensional SDS-PAGE confirms that the intermediate
mobility dimer bands contain EmrE(Cin) and EmrE(Cout) in
amounts that reflect their expression levels (Fig. 2B). These
results imply that the formation of the antiparallel EmrE(Cin)/
FIGURE 2. Analysis of dimer formation by BN-PAGE. A, BN-PAGE of EmrE(WT) (E), EmrE(Cin) (‚), EmrE(Cout) (ƒ), and co-expressed versions. Monomeric (M),
dimeric (D), and tetrameric (T) forms and their composition are indicated. Note that EmrE(Cout) migrates faster than EmrE(Cin) and EmrE(WT) on BN-PAGE,
opposite to the situation for SDS-PAGE. B, two-dimensional SDS-gel of BN-PAGE separated samples of EmrE(Cin), EmrE(Cout), co-expressed EmrE(Cin)/EmrE-
(Cout), and co-expressed EmrE(Cout)/EmrE(Cin). C, SDS-PAGE of the same samples as in A and B (co-expressed EmrE(Cin)/EmrE(Cout) and co-expressed EmrE(Cout)/
EmrE(Cin)), illustrating that the relative expression levels depend on the cloning site (MCS1, MCS2) in the vector. The protein encoded by the gene in MCS1
tends to be more highly expressed than the gene in MCS2.
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EmrE(Cout) heterodimer is favored over either of the two par-
allel homodimers.
Co-expression of EmrE(WT) and EmrE(Cout) (Fig. 2A, lane
8) yields two bands: one corresponding to the EmrE(WT)
homodimer (upper band) and one of intermediatemobility that
presumably corresponds to EmrE(WT)/EmrE(Cout) het-
erodimers. No EmrE(Cout) homodimer and very little EmrE-
(Cout) monomer is seen, most likely because EmrE(WT) is pro-
duced at somewhat higher levels than EmrE(Cout) in this case.
We conclude that the EmrE(WT) homodimer and the
EmrE(WT)/EmrE(Cout) heterodimer have comparable
stabilities.
Unlike EmrE(Cout), both EmrE(WT) and EmrE(Cin)
homodimers have the same mobility in BN-PAGE. Therefore,
co-expression yields only a single dimer band (Fig. 2A, lanes 1,
3, and 7). In an attempt to detect EmrE(WT)/EmrE(Cin) het-
erodimers, EmrE(WT) was modified by the addition of a
27-residue C-terminal Myc-His tag; incidentally, addition of
this tag has been found to lead to a partial shift in the topology
(7). As shown in Fig. 3, the EmrE(WT)-Myc-His construct (lane
2) migrates mainly as a homodimer on BN-PAGE. Co-expres-
sion with either EmrE(Cin) or EmrE(Cout) leads to formation of
heterodimers (Fig. 3, lanes 3 and 4), although the efficiency of
EmrE(WT)-Myc-His/EmrE(Cout) heterodimer formation is
lower than that seen with untagged EmrE(WT)/EmrE(Cout)
(Fig. 2A, lane 8). We conclude that both EmrE(Cin) and EmrE-
(Cout) form heterodimers with EmrE(wt)-MycHis, and, seeing
that EmrE(WT)/EmrE(Cout) heterodimers can be detected on
BN-PAGE, that EmrE(Cin) also forms heterodimers with
untagged EmrE(WT).
Heat-induced Disruption and Reassembly of EmrE Homo-
and Heterodimers—The EmrE(WT) homodimer is exception-
ally stable inDDMbut can be disrupted by heating to 60 °C (16).
We took advantage of this observation to further assess the
stabilities of the EmrE(Cin) and EmrE(Cout) homodimers rela-
tive to the EmrE(Cin)/EmrE(Cout) heterodimer.
First, we confirmed that theDDM-solubilized EmrE(Cin) and
EmrE(Cout) homodimers are stable when mixed without heat-
ing. As seen in Fig. 4A, if cells expressing either EmrE(Cin) or
EmrE(Cout) (lanes 1 and 6) are mixed immediately after har-
vesting (lane 3), or if purified membrane fractions from such
cells aremixed (lane 4), no EmrE(Cin)/EmrE(Cout) heterodimer
is seen by BN-PAGE afterDDMsolubilization. The same is true
if DDM-solubilized EmrE(Cin) and EmrE(Cout) are mixed and
kept at 4 °C prior to BN-PAGE (Fig. 4B, lane 3). In contrast,
when roughly equal amounts of DDM-solubilized EmrE(Cin)
and EmrE(Cout) are mixed and then incubated at 60 °C for at
least 10 min prior to analysis by BN-PAGE, a substantial
amount of EmrE(Cin)/EmrE(Cout) heterodimer is formed (Fig.
4B, lanes 4–6). Heat treatment of DDM-solubilized
EmrE(WT)-Myc-His mixed with either EmrE(Cin) or EmrE-
(Cout) gives similar results (Fig. 4C) except that the relative
amount of heterodimer versus homodimer is lower, as seen also
in the co-expression experiments (Fig. 3).
Comparing the relative amounts of homodimer and het-
erodimer seen after mixing and heating of DDM-solubilized
EmrE(Cin) and EmrE(Cout) (Fig. 4B) to those seen upon co-ex-
pression of EmrE(Cin) andEmrE(Cout) in the same cell (Fig. 2A),
it is clear that the amount of remaining homodimer is higher in
themixed sample. A possible explanation for this discrepancy is
that, following heat disruption of theDDM-solubilized, parallel
EmrE(Cin) and EmrE(Cout) homodimers, the monomers, no
longer being constrained by a lipid bilayer, reassemble prefer-
entially into antiparallel homodimers and EmrE(Cin)/EmrE-
(Cout) heterodimers of roughly equal stability (Fig. 5A).
If this explanation is correct, heat treatment of DDM-solubi-
lized EmrE(Cin)/EmrE(Cout) heterodimers obtained by co-ex-
pression should give the same final distribution of homo- and
heterodimers as that obtained after heat treatment of separately
produced EmrE(Cin) and EmrE(Cout) homodimers. This is
indeed the case (Fig. 5B). For both EmrE(Cin)EmrE(Cout) and
EmrE(Cin)/EmrE(Cout), the distributions converge on a distri-
bution composed of45%EmrE(Cin)/EmrE(Cout) heterodimer
and27% each of the EmrE(Cin) and EmrE(Cout) homodimers,
i.e. a 1:1.7:1 distribution of EmrE(Cin) homodimer:EmrE(Cin)/
EmrE(Cout) heterodimer:EmrE(Cout) homodimer (Fig. 5C).
This is remarkably close to the 1:2:1 distribution that would be
expected if all three kinds of dimers were of exactly equal sta-
bility. It thus appears that the fixed topology EmrE(Cin) and
EmrE(Cout) constructs reassemble into antiparallel rather than
parallel homodimers and that the antiparallel homodimers and
the antiparallel heterodimers are of comparable stabilities.
DISCUSSION
The EmrEmultidrug resistance protein is the best character-
ized of a class of membrane proteins that have a dual topology,
i.e. the polypeptide chains insert into the membrane in such a
way that the final population is roughly a 1:1 mixture of mole-
FIGURE 3. BN-PAGE of EmrE(WT)-MycHis, co-expressed EmrE(WT)-Myc-
His/EmrE(Cin), and co-expressed EmrE(WT)-Myc-His/EmrE(Cout). The
compositions of the different dimers are indicated by the same symbols as
described in the legend to Fig. 2. EmrE(Cin) and EmrE(Cout) are included for
comparison.
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cules with a Cin and a Cout orientation (7, 8). In most, if not all,
cases the active form of a dual-topology protein is expected to
be a homodimer or a higher oligomer. A priori, dimers of dual-
topology proteins could be formed between monomers that
have the same orientation in themembrane (parallel dimers) or
opposite orientations (antiparallel dimers), and higher-order
oligomers could also be formed with varying numbers of paral-
lel and antiparallel monomers.
Despite a multitude of studies, the active conformation of
EmrE is still contentious: although the arguments for a dual
topology of themonomer now seem compelling (4–10) and the
case for a homodimer being the minimal functional unit is
strong (3), there are data favoring both an antiparallel and a
parallel arrangement of the monomers in the active dimer (7,
11, 12, 17). In fact, a recent model proposes that both the par-
allel and antiparallel dimers are active but that the affinity for
parallel association is higher than for antiparallel association
(13). Here, we have revisited the conformation of EmrE dimers,
using both spontaneous cross-linking of single-Cys EmrE
mutants and BN-PAGE analysis of singly expressed or co-ex-
pressed EmrE(WT), EmrE(Cin), and EmrE(Cout) constructs.
EmrE(Cin) and EmrE(Cout) were originally designed to have a
strong preference for either the Cin or the Cout topology, in
contrast to EmrE(WT) that has a dual topology (4). Already at
very low expression levels, co-expression of EmrE(Cin) and
EmrE(Cout) imparts the same level of EtBr resistance to cells as
does low level expression of EmrE(WT), whereas when
expressed on their own at low levels, neither EmrE(Cin) nor
EmrE(Cout) impart significant resistance (4). Because the two
constructs have been shown by reporter fusion analysis (4) and
by cysteine labeling (Fig. 1B) to have opposite membrane ori-
entations in the inner membrane of E. coli, these results sug-
gested that an antiparallel dimer is the more active species.
Because EmrE(Cin) and EmrE(Cout) have slightly different
mobilities both during SDS-PAGE and BN-PAGE, we can read-
ily differentiate between homo- and heterodimers of thesemol-
ecules by gel electrophoresis, and we can also detect het-
erodimers between EmrE(Cin) or EmrE(Cout) and EmrE(WT)
in this way. Strikingly, both spontaneous cysteine cross-linking
and BN-PAGE show efficient formation of homodimers when
EmrE(WT), EmrE(Cin), and EmrE(Cout) are expressed alone
(Figs. 1C and 2). Because EmrE(Cin) and EmrE(Cout) both have
unique membrane topologies, this strongly suggests that paral-
lel EmrE(Cin) and EmrE(Cout) homodimers can form in the
inner membrane. However, only the dual-topology protein
EmrE(WT) imparts robust EtBr resistance when expressed at
FIGURE 4. EmrE(Cin) and EmrE(Cout) homodimers reassemble into a mixture of EmrE(Cin)/EmrE(Cout) heterodimers, EmrE(Cin) homodimers, and EmrE-
(Cout) homodimers after heating to 60 °C and cooling. A, BN-PAGE of cells expressing EmrE(Cin) and cells expressing EmrE(Cout) that were mixed before lysis
(lane 3) or mixed after membrane collection but before solubilization in DDM (lane 4). EmrE(Cin) (lane 1), co-expressed EmrE(Cin)/EmrE(Cout) (lane 2), co-ex-
pressed EmrE(Cout)/EmrE(Cin) (lane 5), and EmrE(Cout) (lane 6) are included for comparison. B, BN-PAGE of DDM-solubilized EmrE(Cin) mixed with DDM-
solubilized EmrE(Cout) and incubated at either 4 °C or 60 °C for different times as indicated (lanes 3– 6). EmrE(Cin) (lane 1), co-expressed EmrE(Cin)/EmrE(Cout)
(lane 2), and EmrE(Cout) (lane 7) are included for comparison. C, BN-PAGE of DDM-solubilized EmrE(Cin) mixed with DDM-solubilized EmrE(WT)-Myc-His (lanes
1– 4) and of EmrE(Cout) mixed with DDM-solubilized EmrE(WT)-Myc-His (lanes 5– 8) incubated at either 4 or 60 °C for different times as indicated. The compo-
sition of the different dimers are indicated by the same symbols as described in the legend to Fig. 2.
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low levels in standard strains (4), suggesting that parallel EmrE-
(Cin) and EmrE(Cout) homodimers have at best a marginal
activity compared with EmrE(WT).
A different picture emerges when EmrE(Cin) and EmrE(Cout)
are co-expressed in the same cell. In this case, the heterodimer
is the dominant species, as seen both by the inhibition of spon-
taneous disulfide bond formation and BN-PAGE. The antipar-
allel EmrE(Cin)/EmrE(Cout) heterodimer is thus considerably
more stable in vivo than either of the two parallel homodimers,
and the EtBr resistance of cells co-expressing EmrE(Cin) and
EmrE(Cout) (4) clearly correlates with the presence of the
antiparallel heterodimer.
Finally, when DDM-solubilized EmrE(Cin)/EmrE(Cout) het-
erodimer is heat-treated at 60 °C and then cooled, the mole-
cules reassemble into an 1:2:1 mixture of EmrE(Cin)
homodimer, EmrE(Cin)/EmrE(Cout) heterodimer, and EmrE-
(Cout) homodimer; the same final mixture is obtained if sepa-
rate samples of DDM-solubilized EmrE(Cin) and EmrE(Cout)
parallel homodimers aremixed and heated. Consistent with the
idea that antiparallel dimers are more stable than parallel
dimers, we propose that heating leads to dimer disassembly and
micelle mixing, and that upon cooling the monomers reassem-
ble into antiparallel homo- and heterodimers of comparable
stability. This kind of heat-induced rearrangement can only
happen in detergent solution and not in an intact membrane.
Taken together, our results suggest that an antiparallel
arrangement of the subunits in the EmrE(WT) dimer is more
stable than a parallel organization and likely corresponds to the
active form of the protein in vivo. However, unless EmrE(WT)
is produced as a precisely balanced mixture of Cin- and Cout-
orientated monomers, some parallel dimers will inevitably
form, in addition to the dominating antiparallel dimers. Are
such parallel dimers of some functional relevance, and are the
critical monomer-monomer interactions that drive formation
of parallel dimers maintained by selection? As pointed out by
Schuldiner (13), it will be interesting to try to understand how a
FIGURE 5. EmrE(Cin)/EmrE(Cout) heterodimers reassemble into a mixture of EmrE(Cin)/EmrE(Cout) heterodimers, EmrE(Cin) homodimers, and EmrE-
(Cout) homodimers after heating to 60 °C and cooling. A, schematic figure summarizing the proposed rearrangement of homodimers and the formation of
heterodimers after mixing and heating DDM-solubilized EmrE(Cin) and EmrE(Cout). The starting point (I) indicates cells expressing EmrE(Cin) (triangles) and cells
expressing EmrE(Cout) (inverted triangles). Solubilization (II) preserves the native organization of the dimers. After mixing of micelles (III), the native organization
is preserved (IV), unless the micelles are heated and then cooled (V). Heat treatment results in a 1:2:1 mixture of antiparallel EmrE(Cin) homodimers, EmrE(Cin)/
EmrE(Cout) heterodimers, and EmrE(Cout) homodimers. B, BN-PAGE of DDM-solubilized co-expressed EmrE(Cin)/EmrE(Cout) (lanes 2– 4) and co-expressed EmrE-
(Cout)/EmrE(Cin) (lanes 5–7) incubated at 60 °C for the indicated times. Co-expressed but unheated EmrE(Cin)/EmrE(Cout) (lane 1) and co-expressed EmrE(Cout)/
EmrE(Cin) (lane 8) samples are included for comparison. C, quantitation of dimer disruption and reassembly of DDM-solubilized samples of separately expressed
EmrE(Cin) and EmrE(Cout) (left panel; cf. Fig. 4B) and of co-expressed EmrE(Cin)/EmrE(Cout) (middle panel; cf. Fig. 5B) after incubation at 60 °C for the indicated
times and cooling. The fractions of the different dimeric forms are shown as a function of incubation time at 60 °C. Quantitation of the three dimer peaks was
done by fitting of three Gaussians to the scanned density in this region of the gel using the QtiPlot software, as in the example shown (right panel); au, arbitrary
units. Because of the rather large peak overlaps, the width of each peak was set manually to the same constant value for the three peaks before the fitting to
ensure a reproducible fit. 10, 10 min; 20, 20 min; 30, 30 min.
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single protein can form both antiparallel and parallel dimers,
albeit of somewhat different stabilities.
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